Washington, D.C. (September 9, 2022) – Sterne, Kessler, Goldstein & Fox is pleased to announce it has been selected as a winner of one of this year’s Hatch-Waxman Impact Cases of the Year Awards at the 2022 LMG Life Sciences Americas Awards.

During a ceremony in New York, NY on September 8, Sterne Kessler was noted for its work in Adapt Pharma v. Teva (Fed Cir 2022). To learn more about the case, please click here.

Sterne Kessler was a finalist in three other law firm categories, including Intellectual Property Boutique Firm of the Year, Patent Strategy Firm of the Year, and Inter-Partes Review Firm of the Year. In addition, the following Sterne Kessler directors were shortlisted for individual awards:

This is the 10th consecutive year that Sterne Kessler and its directors have been recognized by LMG Life Sciences for outstanding achievements in life sciences intellectual property work.

The LMG Life Sciences Awards recognize the best in practice in the industry. Award winners are determined through a rigorous research process that is geared toward identifying excellence in legal service over a 12-month period.

About Sterne, Kessler, Goldstein & Fox

Based in Washington, D.C. and renowned for more than four decades for dedication to the protection, transfer, and enforcement of intellectual property rights, Sterne, Kessler, Goldstein & Fox is one of the most highly regarded intellectual property specialty law firms in the world. Its team of attorneys, registered patent agents, students, and technical specialists include some of the country’s most respected practitioners of IP law tackling innovations across a broad spectrum of industries. The firm’s practitioners hold over 50 masters and over 60 doctorate degrees in science or engineering and represent Fortune 500 companies, entrepreneurs, start-ups, inventors, venture capital firms, and universities in a client service driven environment that is welcoming, inclusive, and intellectually stimulating.

© 2022 Sterne, Kessler, Goldstein & Fox PLLC